ITI-007 for Agitation in Dementia
Language
UndefinedPurpose:To study the use of ITI-007 to treat agitation in people with dementia, including Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - August 31, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Candesartan's Effects on Alzheimer's Disease and Related Biomarkers
Language
UndefinedPurpose: To investigate the effect of candesartan, a blood pressure medication, on cognitive function in people with mild cognitive impairment. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - August 31, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
ALZT-OP1 for Early-Stage Alzheimer's Disease
< div class= " form-item form-type-item " > < label > Language < /label >
Undefined < /div > < div class= " field field-name-body field-type-text-with-summary field-label-hidden " > < div class= " field-items " > < div class= " field-item even " property= " content:encoded " > < div class= ' syndicate ' > < p > < strong > Purpose: < /strong > To test ALZT-OP1 as a treatment for cognitive and functional decline in people with early-stage Alzheimer & #39;s disease. < /p > < /div > < /div > < /div > < /div > < span property= " dc:title " content= " ALZT-OP1 for Early-Stage Alzheimer & #039;s Disease " class= " rdf-meta ...
Source: Alzheimers Clinical Trials - June 22, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
ALZT-OP1 for Early-Stage Alzheimer's Disease
Language
Undefined
Purpose: To test ALZT-OP1 as a treatment for cognitive and functional decline in people with early-stage Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - June 22, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
TAK-071 for Mild Cognitive Impairment and Mild Alzheimer's Disease
< div class= " form-item form-type-item " > < label > Language < /label >
Undefined < /div > < div class= " field field-name-body field-type-text-with-summary field-label-hidden " > < div class= " field-items " > < div class= " field-item even " property= " content:encoded " > < div class= ' syndicate ' > < p > < strong > Purpose: < /strong > To assess the safety, tolerability, and pharmacokinetics of the experimental drug TAK-071 for mild cognitive impairment and mild Alzheimer & #39;s disease. < /p > < /div > < /div > < /div > < /div > < span property= " dc:title " content= " TAK-071 for Mild Cognitive Impairment and...
Source: Alzheimers Clinical Trials - June 22, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
TAK-071 for Mild Cognitive Impairment and Mild Alzheimer's Disease
Language
Undefined
Purpose: To assess the safety, tolerability, and pharmacokinetics of the experimental drug TAK-071 for mild cognitive impairment and mild Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - June 22, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Aerobic Exercise and Cognitive Training in Older Adults
Language
Undefined
Purpose: To examine the impact of a combined cognitive training and aerobic exercise intervention in sedentary older adults. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - June 22, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Repetitive Transcranial Magnetic Stimulation for Dementia
Language
Undefined
Purpose: To determine if repetitive transcranial magnetic stimulation improves cognitive function in people with mild to moderate cognitive impairment or dementia. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - June 22, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
LY3303560 Study
Language
Undefined
Purpose: To study the safety and tolerability of the experimental drug LY3303560. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 13, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Dietary Intervention in Cognitive Aging
Language
Undefined
Purpose: To test two dietary interventions in overweight, middle-aged individuals with subjective memory complaints. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 13, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
ACI-24 Vaccine in Adults with Down Syndrome
Language
Undefined
Purpose: To test the ACI-24 vaccine in adults with Down syndrome. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 13, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Brain Amyloid Retention After Sleep
Language
Undefined
Purpose: To compare the brain's removal of waste after a good night's sleep and after sleep deprivation. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 13, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
< div class= " form-item form-type-item " > < label > Language < /label >
Undefined < /div > < div class= " field field-name-body field-type-text-with-summary field-label-hidden " > < div class= " field-items " > < div class= " field-item even " property= " content:encoded " > < div class= ' syndicate ' > < p > < strong > Purpose: < /strong > To establish a bank of blood, cerebrospinal fluid, imaging, and clinical data to be used in Alzheimer & #39;s disease research. < /p > < /div > < /div > < /div > < /div > < span property= " dc:title " content= " Rocky Mountain Alzheimer & #039;s Disease Center Longitudinal Biomar...
Source: Alzheimers Clinical Trials - May 13, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
Language
Undefined
Purpose: To establish a bank of blood, cerebrospinal fluid, imaging, and clinical data to be used in Alzheimer's disease research. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 13, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Exendin-4 in Alzheimer's Disease
< div class= " form-item form-type-item " > < label > Language < /label >
Undefined < /div > < div class= " field field-name-body field-type-text-with-summary field-label-hidden " > < div class= " field-items " > < div class= " field-item even " property= " content:encoded " > < div class= ' syndicate ' > < p > < strong > Purpose: < /strong > To test Exendin-4 (exenatide), a diabetes drug, as a treatment for early-stage Alzheimer & #39;s disease or mild cognitive impairment. < /p > < /div > < /div > < /div > < /div > < span property= " dc:title " content= " Exendin-4 in Alzheimer & #039;s Disease " class= " rdf-meta e...
Source: Alzheimers Clinical Trials - May 10, 2016 Category: Geriatrics Authors: rmachado Source Type: clinical trials
